Long-term consequences of stopping HBIG and/or nucleotide analogues in liver transplant recipients administered hepatitis B vaccination to prevent HBV reinfection

Recorded On: 06/13/2019

HBV: Withdrawal of HBIG and/or NAs after liver transplant in HBV

Key:

Complete
Failed
Available
Locked
Article
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. HBV: Withdrawal of HBIG and/or NAs after liver transplant in HBV